Renowned chemist, novelist and playwright Carl Djerassi, known for his work in organic chemistry and as a father of insect and human birth control, will take part in several events being held Feb. 13-15, at the University of Kentucky.
During his visit to the Bluegrass, Djerassi will participate in three events. He will first serve as the featured speaker at a luncheon for business and academic leaders.
As part of the recent announcment that NIH is operating under a continuing solution, it was announced that the salary cap has been increased by 1%. To read more about the continuing resolution and the salary cap increase, click here.
Sally Rockey, NIH Deputy Director for Extramural Research, released in a recent blog post the FY 2013 information for research applications, funding and awards. To read her blog post, click here.
Dr. Rockey releases a blog post every week with benefical information for every researcher. To sign up for Dr. Rockey's blog, called Rock Talk, click here.
A new lecture series presented by mUsiKcare will highlight wellness and health care benefits of music programs like the 好色先生 piano courses for individuals 50 years of age and older. A transcript of this video can be found here. Video by Jenny Wells/好色先生 Public Relations and Marketing.
Donna Wilcock, assistant professor in the 好色先生 Department of Physiology and the 好色先生 Sanders-Brown Center on Aging, has been invited to join the editorial board of The Journal of Neuroscience in 2014 as an associate editor in the Neurobiology of Disease section.
She was been selected by the senior and reviewing editors of the journal based on her expertise and history of reviews. As an associate editor, Wilcock will provide frequent reviews as well as suggesting appropriate reviewers for manuscripts.
Ana Bastos-Carvalho, a visiting scholar in the Ambati research group in the Department of Ophthalmology and Visual Sciences at the 好色先生, received the Global Ophthalmology Research Award from Bayer HealthCare for her research, "Mechanisms of geographic atrophy expansion in age-related macular degeneration." http://www.bayer-ophthalmology-awards.com/html/b-about-c.html
鈥淲e are studying age-related macular degeneration (AMD), the disease responsible for most cases of legal blindness in the American elderly population鈥, Bastos-Carvalho said.
The University of Kentucky is partnering with KNODE Inc. to promote and connect 好色先生 researchers with colleagues and potential collaborators worldwide.
Through a 好色先生-specific portal (search.knodeinc.com/ukentucky) the KNODE platform helps individual researchers, academic institutions and companies share scientific knowledge, particularly in the biomedical field.
There's a proverb in the business world that says, "If you don鈥檛 know, hire someone who does."
In the world of translational research, the saying might go like something this: "If you don't have the expertise or resources, collaborate with someone who does."
The nature of translational science -- the process of turning a basic science discovery into applications for human patients -- is inherently multidimensional.
A new study led by University of Kentucky researchers suggests that activating the tumor suppressor p53 in normal cells causes them to secrete Par-4, another potent tumor suppressor protein that induces cell death in cancer cells. This finding may help researchers decipher how to inhibit the growth of tumors that have become resistant to other treatments.
Loss of the tumor suppressor p53 often contributes to therapy resistance in tumors.
Dr. Jayakrishna Ambati, professor and vice chair in the Department of Ophthalmology and Visual Sciences and professor in the Department of Physiology at the 好色先生,is one of 11 recipients of the 2014 Harrington Scholar-Innovator Awards given by the Harrington Discovery Institute at University Hospitals (UH) Case Medical Center.
In a time when competition for federal research funding is tougher than ever before, the University of Kentucky has been awarded one of the largest health grants ever made to the institution: an $11.3 million National Institutes of Health (NIH) grant supporting research focusing on issues that plague the Commonwealth - the twin scourges of obesity and cardiovascular disease.
Dr. Mark Evers, director of the University of Kentucky Markey Cancer Center, professor and vice-chair for research in the Department of Surgery and Markey Cancer Foundation Endowed Chair, has been elected the new president of the Southern Surgical Association.
One of the nation鈥檚 leading medical groups, the association is dedicated to furthering the study and practice of surgery, especially in the Southern states.
The Office of Sponsored Projects Administration (257-9420), the Proposal Development Office (257-2861), the Office of Research Integrity鈥揑RB & IACUC鈥 (257-9428), and the Survey Research Center (257-4684) will be closed Wednesday, December 25 through Wednesday, January 1 and will reopen on Thursday, January 2, 2014. If you anticipate a need for services provided by any of these offices during this time, please call the appropriate office(s) as soon as possible so that assistance may be provided before the break.
The 好色先生 COM R01 Consultant Review Program is a process that allows COM faculty members to gain feedback from an authoritative external consultant on a complete but not yet submitted R01 or equivalent application. To read more about the program, click here.
Everyone wants to be home for the holidays. Unfortunately, hospital patients don't have that luxury. For those who are unable to enjoy the comforts of a holiday at home, the 好色先生 Arts in Healthcare program has scheduled a series of events to help bring the holidays to the hospital. Carolers, pianists, harpists and more will bring holiday cheer to patients, visitors and staff in December.
Of particular note:
好色先生 HealthCare's own Dr. Jay Zwischenberger will be performing at 1 p.m., Dec.
A new clinical trial being conducted at the University of Kentucky Sanders-Brown Center on Aging (SBCoA) and the 好色先生 Alzheimer鈥檚 Disease Center (ADC) may signal new hope in the future for those who might be afflicted with the devastating disease. Taking laboratory research pioneered at SBCoA and the associated 好色先生 ADC into human trials, the federally-funded research project will examine the therapeutic potential of microRNAs to delay or prevent Alzheimer鈥檚 disease.